Nature - Issue - nature.com science feeds
Author Correction: SLAMF6 as a drug-targetable suppressor of T cell immunity against cancer Bin Li · Ming-Chao Zhong · Cristian Camilo Galindo · Jiayu Dou · Jin Qian · Zhenghai Tang · Dominique Davidson · André Veillette
Nature, Published online: 13 March 2026; doi:10.1038/s41586-026-10376-zAuthor Correction: SLAMF6 as a drug-targetable suppressor of T cell immunity against cancer
13 March 2026 at 08:00

Author Correction: SLAMF6 as a drug-targetable suppressor of T cell immunity against cancer

Nature - Issue - nature.com science feeds

By: Bin Li · Ming-Chao Zhong · Cristian Camilo Galindo · Jiayu Dou · Jin Qian · Zhenghai Tang · Dominique Davidson · André Veillette

13 March 2026 at 08:00

Nature, Published online: 13 March 2026; doi:10.1038/s41586-026-10376-z

Nature - Issue - nature.com science feeds
Structures of Marburgvirus glycoprotein and its complex with NPC1 receptor Gang Ye · Fan Bu · Hailey Turner-Hubbard · Morgan Herbst · Lanying Du · Ge Yang · Bin Liu · Fang Li
Nature, Published online: 11 March 2026; doi:10.1038/s41586-026-10240-0Marburgvirus glycoprotein binds to the endosomal receptor NPC1 in a distinct orientation with higher affinity compared with Ebola virus glycoprotein, accompanied by fusion-relevant rearrangements, enabling more efficient viral entry.
11 March 2026 at 08:00

Structures of Marburgvirus glycoprotein and its complex with NPC1 receptor

Nature - Issue - nature.com science feeds

By: Gang Ye · Fan Bu · Hailey Turner-Hubbard · Morgan Herbst · Lanying Du · Ge Yang · Bin Liu · Fang Li

11 March 2026 at 08:00

Nature, Published online: 11 March 2026; doi:10.1038/s41586-026-10240-0

Marburgvirus glycoprotein binds to the endosomal receptor NPC1 in a distinct orientation with higher affinity compared with Ebola virus glycoprotein, accompanied by fusion-relevant rearrangements, enabling more efficient viral entry.

Nature - Issue - nature.com science feeds
Risk-adaptive therapy guided by dynamic ctDNA in nasopharyngeal carcinoma Jiawei Lv · Dan-Xue Zheng · Jin-Hui Liang · Ning Zhang · Zu-Lu Ye · Xu-Dong Xu · Melvin. L. K. Chua · Lu-Lu Zhang · Zi-Ming Du · Zi-Chen Zhang · Wen-Fei Li · Ling-Long Tang · Lei Chen · Yan-Ping Mao · Rui Guo · Yu-Pei Chen · Li Lin · Yuan Zhang · Xu Liu · Cheng Xu · Zhi-Xuan Li · Ling-Xin Xu · Pan-Yang Yang · Kun Chen · Deng Bin · Tian-Sheng Gao · Jian-Ye Yan · Lu-Si Chen · Shao Hui Huang · Hong-Yun Zhao · Shu-Bin Hong · Yu-Sheng Jie · Hui-Ling Huang · Xu-Hua Tang · Jing-Ping Yun · Li-Zhi Liu · Li Tian · Hao-Jiang Li · Ji-Bin Li · Guan-Qun Zhou · Jun Ma · Ying Sun
Nature, Published online: 11 March 2026; doi:10.1038/s41586-026-10244-wA clinical trial testing whether monitoring ctDNA clearance during treatment for nasopharyngeal cancer could be used to inform decisions about an individual’s subsequent therapeutic programme shows promising results.
11 March 2026 at 08:00

Risk-adaptive therapy guided by dynamic ctDNA in nasopharyngeal carcinoma

Nature - Issue - nature.com science feeds

By: Jiawei Lv · Dan-Xue Zheng · Jin-Hui Liang · Ning Zhang · Zu-Lu Ye · Xu-Dong Xu · Melvin. L. K. Chua · Lu-Lu Zhang · Zi-Ming Du · Zi-Chen Zhang · Wen-Fei Li · Ling-Long Tang · Lei Chen · Yan-Ping Mao · Rui Guo · Yu-Pei Chen · Li Lin · Yuan Zhang · Xu Liu · Cheng Xu · Zhi-Xuan Li · Ling-Xin Xu · Pan-Yang Yang · Kun Chen · Deng Bin · Tian-Sheng Gao · Jian-Ye Yan · Lu-Si Chen · Shao Hui Huang · Hong-Yun Zhao · Shu-Bin Hong · Yu-Sheng Jie · Hui-Ling Huang · Xu-Hua Tang · Jing-Ping Yun · Li-Zhi Liu · Li Tian · Hao-Jiang Li · Ji-Bin Li · Guan-Qun Zhou · Jun Ma · Ying Sun

11 March 2026 at 08:00

Nature, Published online: 11 March 2026; doi:10.1038/s41586-026-10244-w

A clinical trial testing whether monitoring ctDNA clearance during treatment for nasopharyngeal cancer could be used to inform decisions about an individual’s subsequent therapeutic programme shows promising results.

Normal view